Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by JOYCE R TODD

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ACTActavis plcJOYCE R TODDCFO-GlobalMay 09, 2014Option Exercise$197.052,537499,9162,537May 13, 2014, 05:17 PM
ACTActavis plcJOYCE R TODDCFO-GlobalDec 06, 2013Sale$165.8314,6002,421,06147,100Dec 06, 2013, 04:15 PM
ACTActavis plcJOYCE R TODDCFO-GlobalNov 05, 2013Sale$157.0115,0002,355,15062,100Nov 07, 2013, 04:16 PM
ACTActavis plcJOYCE R TODDCFO-GlobalNov 06, 2013Sale$158.427,5001,188,15054,600Nov 07, 2013, 04:16 PM
ACTActavis, Inc.JOYCE R TODDCFO-GlobalSep 30, 2013Option Exercise$144.0045,1016,494,54473,812Oct 02, 2013, 09:10 PM
ACTActavis, Inc.JOYCE R TODDCFO-GlobalAug 14, 2013Sale$137.9815,0002,069,75084,470Aug 15, 2013, 04:46 PM
ACTActavis, Inc.JOYCE R TODDCFO-Global & PAOMar 15, 2013Option Exercise$91.5993185,27095,470Mar 18, 2013, 04:29 PM
ACTActavis, Inc.JOYCE R TODDCFO-Global & PAOMar 05, 2013Option Exercise$86.461,919165,91781,725Mar 07, 2013, 02:56 PM
ACTActavis, Inc.JOYCE R TODDCFO-Global & PAOMar 02, 2013Option Exercise$85.543,834327,96083,644Mar 05, 2013, 07:19 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDCFO-Global & PAOAug 01, 2012Option Exercise$34.2613,250453,99791,485Aug 01, 2012, 06:49 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDCFO-Global & PAOAug 01, 2012Sale$78.609,824772,16688,873Aug 01, 2012, 06:49 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDCFO-Global & PAOMay 25, 2012Option Exercise$26.40513278,235May 29, 2012, 05:34 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOMar 14, 2012Option Exercise$59.211,06763,17778,230Mar 16, 2012, 02:17 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOFeb 24, 2012Option Exercise$58.171,62594,52663,243Feb 28, 2012, 12:21 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOOct 30, 2011Option Exercise$69.351,17581,48664,868Nov 01, 2011, 04:08 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOAug 24, 2011Option Exercise$26.5917,748471,96472,659Aug 26, 2011, 04:38 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOAug 24, 2011Sale$65.466,616433,08366,043Aug 26, 2011, 04:38 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOAug 24, 2011Sale$65.462,924191,4053,283Aug 26, 2011, 04:38 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOJul 27, 2011Option Exercise$64.187,500481,35062,113Jul 28, 2011, 04:21 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOJul 27, 2011Sale$68.417,202492,68954,911Jul 28, 2011, 04:21 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOMay 04, 2011Option Exercise$27.2912,500341,10062,631May 05, 2011, 04:29 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOMay 04, 2011Sale$62.918,018504,41254,613May 05, 2011, 04:29 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDExec Vice Pres. & CFOMar 11, 2011Option Exercise$56.8954430,94846,537Mar 15, 2011, 04:13 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDSr Vice Pres. & CFOMar 05, 2011Option Exercise$56.791,37478,02947,081Mar 08, 2011, 04:30 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDSr Vice Pres. & CFOMar 03, 2011Option Exercise$37.6413,997526,86659,433Mar 07, 2011, 04:16 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDSr Vice Pres. & CFOMar 03, 2011Sale$57.0910,978626,73448,455Mar 07, 2011, 04:16 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDSr Vice Pres. & CFODec 14, 2010Option Exercise$46.3110,000463,10043,167Dec 15, 2010, 04:16 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDSr Vice Pres. & CFODec 14, 2010Sale$49.6010,000496,00038,167Dec 15, 2010, 04:16 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDSr Vice Pres. & CFODec 10, 2010Option Exercise$45.882,500114,68835,667Dec 14, 2010, 04:35 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDSr Vice Pres. & CFODec 10, 2010Sale$49.002,500122,50834,875Dec 14, 2010, 04:35 PM
WPIWATSON PHARMACEUTICALS INCJOYCE R TODDSr Vice Pres. & CFOSep 01, 2010Option Exercise$44.1524410,77333,167Sep 02, 2010, 06:22 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe